BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
Cooral® System Intra-Oral Cooling Device Prevents Oral Mucositis (OM) A New Standard is Set for Preventing One of the Severest Side-Effects of Cancer Treatment LUND, Sweden, Sept. 18, 2020 -- (Healthcare Sales & Marketing Network) -- BrainCool A... Devices, Oncology BrainCool, Cooral System, hypothermia, oral mucositis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2020 Category: Pharmaceuticals Source Type: news

Orfadin(R) (nitisinone) receives positive opinion from CHMP for treatment of AKU
STOCKHOLM, Sept. 18, 2020 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ... Biopharmaceuticals, Regulatory Swedish Orphan Biovitrum, Orfadin, nitisinone, alkaptonuria (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2020 Category: Pharmaceuticals Source Type: news

CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Positive Opinion is the First Regulatory Action for Baricitinib as an Atopic Dermatitis Medicine INDIANAPOLIS, Sept. 18, 2020 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:INCY) announced today that th... Biopharmaceuticals, Dermatology, Regulatory Eli Lilly, Incyte , baricitinib, OLUMIANT, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2020 Category: Pharmaceuticals Source Type: news

Accuray Radixact(R) System with Synchrony(R) Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
First lung case in ASIA, and the first liver case in the world, were treated at Takarazuka City Hospital, Hyogo, Japan Japanese Red Cross Nagoya Daini Hospital, Aichi, and Kishiwada Tokushukai Hospital, Osaka, Japan, have started treating lung cases ... Devices, Oncology Accuray, Radixact System, Synchrony, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2020 Category: Pharmaceuticals Source Type: news

Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
New investment to support advancement of powerful bispecific Gamma-Delta T cell engager programs for the treatment of a broad range of cancers Leading global life sciences venture has invested approx US$1 billion in last two years COPENHAGEN, Denmark... Biopharmaceuticals, Oncology, Venture Capital Novo Ventures, LAVA Therapeutics, gamma-delta T cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2020 Category: Pharmaceuticals Source Type: news

Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology Long-Term Results from WRAP-IT, Data on Impact of Infections Also Published DUBLIN, Sept. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Medt... Devices, Cardiology Medtronic, TYRX Envelope, Absorbable Antibacterial Envelope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2020 Category: Pharmaceuticals Source Type: news

Cygnal Therapeutics Expands Leadership Team with Appointment of John A. Wagner, M.D., Ph.D., as Chief Medical Officer
CAMBRIDGE, Mass., Sept. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, announced today that John A. Wagner, M.D., Ph.D., has joined t... Biopharmaceuticals, Personnel Cygnal Therapeutics, Exoneural Medicine Platform (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2020 Category: Pharmaceuticals Source Type: news

Signifier Medical Technologies Closes $10M Series C Funding Round
BOSTON and LONDON, Sept. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Signifier Medical Technologies ("Signifier"), an innovator in the sleep disordered breathing market, today announced it has closed a circa $10M Series C funding round... Devices, Venture Capital Signifier Medical Technologies, obstructive sleep apnea, neurostimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2020 Category: Pharmaceuticals Source Type: news

ControlRad(R) Announces FDA Clearance and Closing of Series C Financing
ATLANTA, Sept. 15, 2020 -- (Healthcare Sales & Marketing Network) -- ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced t... Devices, Radiology, Venture Capital, FDA ControlRad, ControlRad Trace (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2020 Category: Pharmaceuticals Source Type: news

Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
Experienced industry physician scientist to lead clinical development Co-founder, Dr. Debasish Roychowdhury, to serve as Chief Technology Officer LEXINGTON, Mass., Sept. 15, 2020 -- (Healthcare Sales & Marketing Network) -- Partner Therapeutics, Inc... Biopharmaceuticals, Personnel Partner Therapeutics, LEUKINE, sargramostim (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2020 Category: Pharmaceuticals Source Type: news

CoreLink Releases First-Of-Its-Kind Oblique Lumbar Interbody Fusion Instrument Set With 3D Printed Instruments
CoreLink's new OLIF offering includes approach-specific instruments for lower lumbar spine anterolateral access and fusion. ST. LOUIS, Sept. 15, 2020 -- (Healthcare Sales & Marketing Network) -- CoreLink, LLC, a leading designer and manufacturer of spi... Devices, Orthopaedic, Neurosurgery, Product Launch CoreLink, Oblique Lumbar Interbody Fusion, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2020 Category: Pharmaceuticals Source Type: news

Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
The Companies Have Also Received Approvals in Australia and New Zealand; Combination on Track to Close in Fourth Quarter 2020 HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, Sept. 15, 2020 -- (Healthcare Sales & Marketing Network) -- Mylan (NASDAQ: M... Biopharmaceuticals, Mergers & Acquisitions Mylan, Pfizer, Upjohn (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2020 Category: Pharmaceuticals Source Type: news

Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
Kevin O'Reilly Named Senior Vice President and President of Varian Oncology Systems Stephanie Foster Named Senior Vice President of Global Supply Chain Operations PALO ALTO, Calif., Sept. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Varian ... Devices, Oncology, Personnel Varian, radiotherapy, radiosurgery, proton beam, linac (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2020 Category: Pharmaceuticals Source Type: news

CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
CollPlant has already received first order amounting to hundreds of thousands of U.S. dollars Product distribution in six CIS countries expected to increase clinical use in new patient populations Recent peer-reviewed publication further substantiate... Devices, Regenerative Medicine, Wound Care, Distribution CollPlant, Vergenix Flowable Gel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2020 Category: Pharmaceuticals Source Type: news

Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Leverages proprietary pan-amyloid targeting agents with potential to diagnose and reverse the underlying pathology of systemic amyloid diseases, including AL and ATTR amyloidosis SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 -- (Healthcare Sales & Marketi... Biopharmaceuticals, Venture Capital Attralus, amyloidosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2020 Category: Pharmaceuticals Source Type: news

Targazyme Appoints Jim Caggiano as CEO
CARLSBAD, Calif., Sept. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Targazyme Inc., a late clinical-stage biopharmaceutical company developing novel fucosyltransferase enzyme technologies and products to improve clinical efficacy, safety, and co... Biopharmaceuticals, Personnel Targazyme, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2020 Category: Pharmaceuticals Source Type: news

REYVOW(TM) (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study
REYVOW Showed Significant Therapeutic Gains of 17-21% for Pain Freedom at 2 Hours and Met All 18 Gated Endpoints INDIANAPOLIS, Sept. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Adults who took REYVOW™ (lasmiditan) C-V for their migraine attac... Biopharmaceuticals, Neurology Eli Lilly, REYVOW, lasmiditan, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2020 Category: Pharmaceuticals Source Type: news

Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) OIRD Occurred in 46% of Patients Studied Patients with Respiratory Depression Are 37% More Likely to Experienc... Devices, Monitoring Medtronic, opioid-induced respiratory depression, capnography, pulse oximetry (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2020 Category: Pharmaceuticals Source Type: news

IZI Medical Receives CE Mark Approval for Kiva(TM) VCF Treatment System
OWINGS MILLS, Md., Sept. 10, 2020 -- (Healthcare Sales & Marketing Network) -- IZI Medical Products, LLC ("IZI"), a leading manufacturer of interventional radiology devices, announces that it has received CE Mark approval in Europe for the KivaT... Devices, Interventional, Radiology, Regulatory IZI Medical Products, Kiva , Vertebral Compression Fracture, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2020 Category: Pharmaceuticals Source Type: news

Phosplatin Therapeutics Announces Two Leadership Appointments
Scientific Advisory Board Member Dr. Joseph F. O'Donnell Steps in as Interim Chief Medical Officer; Jason Summa Joins in Newly Created Clinical Development Role NEW YORK, Sept. 9, 2020 -- (Healthcare Sales & Marketing Network) -- Phosplatin Therapeutic... Biopharmaceuticals, Oncology, Personnel Phosplatin Therapeutics, phosphaplatins (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2020 Category: Pharmaceuticals Source Type: news

Lilly Announces Leadership Changes
Patrik Jonsson named Senior Vice President, President of Lilly USA and Chief Customer Officer Ilya Yuffa promoted to Senior Vice President and President of Lilly Bio-Medicines INDIANAPOLIS, Sept. 9, 2020 -- (Healthcare Sales & Marketing Network) -- ... Biopharmaceuticals, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2020 Category: Pharmaceuticals Source Type: news

MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer
Experienced CEO Brings Deep Oncology Drug Development and Company-Building Corporate Experience to Expand Growth in the U.S. CAMBRIDGE, Mass. and YAVNE, Israel, Sept. 9, 2020 -- (Healthcare Sales & Marketing Network) -- MetaboMed, a biopharmaceutical c... Biopharmaceuticals, Oncology, Personnel MetaboMed, cancer metabolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2020 Category: Pharmaceuticals Source Type: news

Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Will commence trading under new Nasdaq Ticker "VYNE", September 8, 2020 Company to ring Nasdaq Closing Bell at 4pm ET today BRIDGEWATER, N.J., Sept. 8, 2020 -- (Healthcare Sales & Marketing Network) -- VYNE Therapeutics Inc. (Nasdaq: VYNE)... Biopharmaceuticals, Dermatology VYNE Therapeutics, Menlo Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif., Sept. 8, 2020 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration (FDA) has granted premarket approval ... Diagnostics, Oncology, FDA Thermo Fisher Scientific, Oncomine Dx Target, NSCLC, GAVRETO, pralsetinib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Ser... Devices, Interventional, Cardiology, Venture Capital Adona Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

Mylan to Acquire Aspen's Thrombosis Business in Europe
Acquisition further complements and expands Mylan's complex injectables offering and presence in hospitals Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS™ HERTFORDSHIRE, England, a... Biopharmaceuticals, Acquisitions Mylan, Aspen Pharmacare (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia
SUZHOU, China and ROCKVILLE, Md., Sept. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),... Biopharmaceuticals, Oncology, FDA Ascentage Pharma, APG-2575, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2020 Category: Pharmaceuticals Source Type: news

Lumenis Announces NuEra(R) Tight with FocalRF(TM) Technology, a Breakthrough in Aesthetic Medical Devices, now available in Europe and the Middle East offering Personalized Body Sculpting Treatments
YOKNEAM, Israel, Sept. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, is proud to announce the revolutionary NuEra Tight with ... Devices, Dermatology, Product Launch Lumenis, NuEra Tight, FocalRF, Fat Reduction, Skin Tightening (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2020 Category: Pharmaceuticals Source Type: news

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
Ordinary Share Purchase price equivalent to $33.00 per ADS, at a premium to the 30-day volume weighted average price ("VWAP") Demonstrates leading biotech investors' strong endorsement of I-Mab's R&D innovation and value generation capabilitie... Biopharmaceuticals, Venture Capital I-Mab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2020 Category: Pharmaceuticals Source Type: news

AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
AbbVie and I-Mab to collaborate on development and commercialization of I-Mab's highly differentiated anti-CD47 monoclonal antibody lemzoparlimab (TJC4) I-Mab to receive upfront payment of USD180 million Potential to explore combination therapies wit... Biopharmaceuticals, Oncology I-Mab, AbbVie, lemzoparlimab, venetoclax, Venclexta (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2020 Category: Pharmaceuticals Source Type: news

Fujifilm Sonosite Receives FDA COVID-19 510(k) Clearance for Comprehensive Point-of-Care Ultrasound Portfolio
BOTHELL, Wash., Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced th... Devices, FDA Fujifilm Sonosite, point-of-care ultrasound, ultrasound, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2020 Category: Pharmaceuticals Source Type: news

Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Board expansion supports ongoing development of cytoDRiVE™ programs and external collaborations CAMBRIDGE, Mass., Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable ce... Biopharmaceuticals, Personnel Obsidian Therapeutics, gene therapies, cytoDRiVE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2020 Category: Pharmaceuticals Source Type: news

Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
SAN FRANCISCO, U.S. and SUZHOU, China, Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medici... Biopharmaceuticals, Regulatory Innovent Biologics, SULINNO , adalimumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2020 Category: Pharmaceuticals Source Type: news

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Funding to advance "home hospital" initiatives with health systems and "beyond the pill" digital therapeutics partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Biofourmis, ... Devices, Venture Capital Biofourmis, digital therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2020 Category: Pharmaceuticals Source Type: news

NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Industry Veteran Brings More Than 20 Years of Corporate Leadership and Investment Banking Expertise BOSTON, Sept. 2, 2020 -- (Healthcare Sales & Marketing Network) -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company ... Biopharmaceuticals, Neurology, Personnel NeuroBo Pharmaceuticals, diabetic neuropathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 2, 2020 Category: Pharmaceuticals Source Type: news

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
KIRKLAND, Wash., Sept. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today a... Devices, Cardiology, Interventional, Regulatory Cardiac Dimensions, Carillon Mitral Contour, mitral regurgitation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 2, 2020 Category: Pharmaceuticals Source Type: news

Letter from Seneca Biopharma's Executive Chairman
GERMANTOWN, Md., Sept. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following let... Biopharmaceuticals Seneca Biopharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 2, 2020 Category: Pharmaceuticals Source Type: news

Smith and Nephew launches NOVOSTITCH(TM) PRO Meniscal Repair System in Europe
Vertically placed, circumferential sutures expand the possibilities of meniscal repair to include Horizontal Cleavage, Radial, Complex and Root tear patterns LONDON, Sept. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN,NYSE... Devices, Orthopaedic, Product Launch Smith & Nephew, NOVOSTITCH PRO, Meniscal Repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 2, 2020 Category: Pharmaceuticals Source Type: news

Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
.S. Centers for Medicare & Medicaid Services (CMS) reimbursement expands access of the FreeStyle Libre 2 system to Medicare patients[1] to better manage their diabetes The FreeStyle Libre 2 technology is the only integrated continuous glucose monitoring... Devices, Monitoring, Endocrinology, Reimbursement Abbott, FreeStyle, Libre 2, continuous glucose monitor, iCGM (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 1, 2020 Category: Pharmaceuticals Source Type: news

MedGyn Completes Acquisition of Thomas Medical
Addition of Thomas Medical's single-use HS Catheters and women's health product lines further strengthens MedGyn's portfolio of U.S. manufactured devices for healthcare professionals across the globe ADDISON, Ill., Sept. 1, 2020 -- (Healthcare Sales & M... Devices, Mergers & Acquisitions MedGyn, Thomas Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 1, 2020 Category: Pharmaceuticals Source Type: news

Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research and Development
Newly created role to oversee R&D organization and advance precision medicine portfolio vision CAMBRIDGE, Mass., Sept. 1, 2020 -- (Healthcare Sales & Marketing Network) -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company foc... Biopharmaceuticals, Personnel Blueprint Medicines, AYVAKIT, avapritinib, gastrointestinal stromal tumor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 1, 2020 Category: Pharmaceuticals Source Type: news

Olive Diagnostics exits Stealth Mode; delivers world's first consumer-use, hands-free, urinalysis solution
World's only working prototype attaches easily to any toilet, instantly providing complete diagnostics, health assessments and early detection of 20+ diseases. MENLO PARK, Calif., Sept. 1, 2020 -- (Healthcare Sales & Marketing Network) -- Olive Diagnos... Diagnostics Olive Diagnostics, K2 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 1, 2020 Category: Pharmaceuticals Source Type: news

10,000th Patient Receives Treatment with ViewRay's MRIdian System
MRI-Guided Radiation Therapy Brings Cutting-Edge Cancer Treatment to Patients Around the World CLEVELAND, Sept. 1, 2020 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to ... Devices, Radiology ViewRay, MRIdian, MRI-guided radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 1, 2020 Category: Pharmaceuticals Source Type: news

Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
MISGAV, Israel, Aug. 31, 2020 -- (Healthcare Sales & Marketing Network) -- Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superf... Devices, Urology, Oncology, Venture Capital Vessi Medical, cryoablation, cryo-spray ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash Transaction drives efficiencies, enhances capabilities and further strengthens Ionis' financial position Transaction is a key step in the evo... Biopharmaceuticals, Mergers & Acquisitions Ionis Pharmaceuticals, Akcea Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, Aug. 31, 2020 -- (Healthcare Sales & Market... Biopharmaceuticals, Generics, Product Launch Mylan, Biocon Ltd, Biocon Biologics India, Semglee, diabetes, insulin glargine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

Qualigen Therapeutics Appoints Amy Broidrick to its Board of Directors
CARLSBAD, Calif., Aug. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today the addition of pharmaceutical executive Amy Broidrick to the company's Board of Directors. Ms. Broidrick's background... Biopharmaceuticals, Oncology, Personnel Qualigen Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 28, 2020 Category: Pharmaceuticals Source Type: news

Leica Microsystems and MellingMedical Sign Distribution Agreement
BUFFALO GROVE, Ill., Aug. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Leica Microsystems, a technology leader in microscope and image analysis solutions, and MellingMedical, a leading supplier of medical supplies, equipment, devices and pharmace... Devices, Distribution Leica Microsystems, MellingMedical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 28, 2020 Category: Pharmaceuticals Source Type: news

Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
Healeon Duet enables customized concentrations of PRP at the point-of-care SOLANA BEACH, Calif., Aug. 27, 2020 -- (Healthcare Sales & Marketing Network) -- Healeon, a wholly owned subsidiary of Bimini Health Tech, announced today it received FDA 510(k)... Devices, FDA Healeon, Healeon Duet, Platelet Rich Plasma, Bimini Health Tech (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2020 Category: Pharmaceuticals Source Type: news

B. Braun Receives FDA Clearance for SpaceStation MRI: Allows Space(R) Infusion Pumps to Continuously Deliver Medications Within the MRI Suite
BETHLEHEM, Pa., Aug. 27, 2020 -- (Healthcare Sales & Marketing Network) -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today that it has received 510(k) clearance from the US Food and Drug Administration f... Devices, Radiology, FDA B. Braun, SpaceStation MRI, Space infusion pump (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2020 Category: Pharmaceuticals Source Type: news